The heterogeneity of iCCA poses significant challenges to both targeted therapy and immunotherapy, necessitating in-depth exploration at the molecular and subtyping levels. Investigating genetic ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed a temporal association between cholangioscopy volume and subsequent cholangiocarcinoma ...

What Is Metastatic Bile Duct Cancer and Its Causes? Bile duct cancer – also called cholangiocarcinoma – is a rare condition. When you have cholangiocarcinoma, cancer cells grow in your bile ducts, ...

Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...

Phase 1b/2 results of a multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin +/- devimistat as first-line therapy for patients with advanced biliary tract cancer (BilT-04). This is an ...

Good science, along with creativity in applying and testing it properly, can be successful against all odds for patients with cholangiocarcinoma. Cholangiocarcinoma, known more commonly as bile duct ...

Bile duct cancer, also known as cholangiocarcinoma, is a rare form of cancer that affects the bile ducts. Two bile ducts in the human body connect the liver and gallbladder to the small intestine.

Gallbladder cancer and cholangiocarcinoma are both biliary cancers. They can cause the same symptoms, but causes and treatments can differ. Gallbladder cancer is cancer of the gallbladder, while ...

Partial bile duct ligation (pBDL) is considered a well-tolerated cholestatic model. Magnetic resonance imaging (MRI) is one of the most widely used tools in noninvasive imaging. However, no systematic ...